Metropolitan Life Insurance Company (MetLife)’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-267
| Closed | -$12.7K | – | 2373 |
|
|
2023
Q3 | $12.7K | Hold |
267
| – | – | ﹤0.01% | 2107 |
|
|
2023
Q2 | $25.5K | Buy |
267
+75
| +39% | +$7.17K | ﹤0.01% | 1798 |
|
|
2023
Q1 | $21.8K | Sell |
192
-21
| -10% | -$2.38K | ﹤0.01% | 1845 |
|
|
2022
Q4 | $23.9K | Hold |
213
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q3 | $27.4K | Buy |
213
+142
| +200% | +$18.3K | ﹤0.01% | 1846 |
|
|
2022
Q2 | $4.88K | Sell |
71
-162
| -70% | -$11.1K | ﹤0.01% | 2340 |
|
|
2022
Q1 | $33.2K | Sell |
233
-458
| -66% | -$65.3K | ﹤0.01% | 1828 |
|
|
2021
Q4 | $115K | Buy |
691
+193
| +39% | +$32.1K | ﹤0.01% | 2391 |
|
|
2021
Q3 | $69.3K | Sell |
498
-477
| -49% | -$66.4K | ﹤0.01% | 2705 |
|
|
2021
Q2 | $465K | Buy |
975
+232
| +31% | +$111K | 0.01% | 1565 |
|
|
2021
Q1 | $306K | Sell |
743
-39
| -5% | -$16.1K | ﹤0.01% | 1730 |
|
|
2020
Q4 | $383K | Hold |
782
| – | – | 0.01% | 1540 |
|
|
2020
Q3 | $443K | Sell |
782
-5
| -0.6% | -$2.83K | 0.01% | 1297 |
|
|
2020
Q2 | $75K | Buy |
+787
| New | +$75K | ﹤0.01% | 2411 |
|
|
2017
Q4 | – | Sell |
-782
| Closed | -$251K | – | 2517 |
|
|
2017
Q3 | $251K | Hold |
782
| – | – | ﹤0.01% | 2150 |
|
|
2017
Q2 | $177K | Buy |
+782
| New | +$177K | ﹤0.01% | 2410 |
|
|
2016
Q4 | – | Sell |
-685
| Closed | -$168K | – | 2638 |
|
|
2016
Q3 | $168K | Buy |
685
+7
| +1% | +$1.72K | ﹤0.01% | 2444 |
|
|
2016
Q2 | $394K | Buy |
678
+355
| +110% | +$206K | ﹤0.01% | 1850 |
|
|
2016
Q1 | $172K | Hold |
323
| – | – | ﹤0.01% | 2259 |
|
|
2015
Q4 | $227K | Buy |
+323
| New | +$227K | ﹤0.01% | 2167 |
|